CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Fulgent Genetics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Fulgent Genetics Inc
4399 SANTA ANITA AVE
Phone: (626) 350-0537p:626 350-0537 EL MONTE, CA  91731  United States Ticker: FLGTFLGT
Business Summary
Fulgent Genetics, Inc. is a technology-based genetic company with a laboratory services business and a therapeutic development business. The Company’s laboratory services business includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile (PK) profile of new and existing cancer drugs. Its technology platform for its laboratory services business includes gene probes, data suppression and comparison algorithms, learning software, and laboratory information management systems. The platform provides a test menu, the ability to rapidly develop and launch new tests and customizable test offerings. The Company also offers next-generation sequencing (NGS) services.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023YesYes--Yes

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus
8071 Medical laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer MingHsieh 68 5/1/2022 5/1/2016
President, Chief Operating Officer JianXie 58 5/1/2022 4/1/2018
Chief Financial Officer PaulKim 56 1/1/2016 1/1/2016
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Fulgent Pharma LLC 4978 Santa Anita Ave. Temple City CA United States
CSI Laboratories 11525 Park Woods Circle Alpharetta GA United States
Cytometry Specialists, Inc. 2580 WESTSIDE PARKWAY ALPHARETTA GA United States
PLUS Diagnostics 825 Rahway Avenue Union NJ United States
Inform Diagnostics 6655 N MacArthur Blvd Irving TX United States

Business Names
Business Name
CSI Laboratories
Cytometry Specialists, Inc.
FLGT
8 additional Business Names available in full report.

General Information
Number of Employees: 1,184 (As of 2/15/2024)
Outstanding Shares: 29,900,666 (As of 3/21/2024)
Shareholders: 14
Stock Exchange: NASD
Federal Tax Id: 812621304
Fax Number: (626) 454-1667


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 23, 2024